Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of MR19D6A versus Rozex Gel in cancerous cutaneous ulcers
jRCT2031200285Completed
- Sponsor
- Maruishi Pharmaceutical Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of metronidazole in Cutaneous ulcer, sponsored by Maruishi Pharmaceutical Co., Ltd. Primary endpoints: Safety (adverse events and clinical parameters), Pharmacokinetics of metronidazole and 2 more. Started Jan 2021; status: completed.
02
Drugs
metronidazole
03
Conditions
Cutaneous ulcer
Beyond the preview
Go deeper on jRCT2031200285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200285.